Skip to main content
. 2018 Apr 26;9:263. doi: 10.3389/fneur.2018.00263

Table 2.

Overview of adverse events in participants who received the allocated intervention.

Adverse event type All (n) Vitamin D3 (n) Placebo (n)
Relapse 1 1 1
Hypercalciuria 5 2 3
Hypocalcemia 0 0 0
Infections
Urinary tract infection 6 3 3
Pharyngitis 1 1 0
Ear infection 2 1 1
Herpes zoster infection 1 1 0
Influenza 3 0 3
Upper respiratory tract infection 4 1 3
Gastrointestinal
Abdominal pain 1 0 1
Stomach discomfort 1 0 1
Cardiovascular
Hypertension 1 0 1
Hypercholesterolemia 1 0 1
Cold extremities 1 0 1
Musculoskeletal
Lumbago 1 0 1
Leg pains 1 1 0
Ruptured ankle ligaments 1 0 1
Achilles tendinosis 1 0 1
Lateral epicondylitis 1 0 1
Other
Pregnancy 1 0 1
Iron deficiency 1 0 1
Headaches 2 2 0
Fatigue 2 1 1
Dizziness 2 2 0
Axillary pains 1 1 0
Globus/tingling sensations during swallowing 2 2 0
Mood swings 2 2 0
Suicidal thoughts 1 0 1